Track record · closed signal

Abbott Laboratories (ABT) — closed signal from March 30, 2026

Partial Published before the outcome was known, scored automatically when the window closed on June 28, 2026.

Predicted vs. what happened

ABT price · publication thesis → realized outcomesplit-adjusted
$103.41 Published $113.75 Target $94.12 Window close $104.77 Peak
$100.00 – $105.00Entry zone — fair-value band
$103.41Published — price the day we called it
$113.75Target — the price the thesis aimed for
$104.77Peak — highest point inside the window, not a realized return
$94.12Window close — end-of-window price, context only

What happened

Partial

Reached 13% of the predicted growth at its peak, without hitting the target.

Peak price
$104.77
peak on March 30, 2026 — not a realized return
Peak gain
+1.3%
peak, from the publication price
Window close
$94.12
end-of-window price, context only
Days to target
—
Window
March 30, 2026 – June 28, 2026

The thesis — published March 30, 2026

Predicted growth
+10%
over the measurement window
Target price
$113.75
the price the thesis aimed for
Entry zone
$100.00 – $105.00
the fair-value band we waited for
Price at publication
$103.41
published March 30, 2026
Confidence
71%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Abbott sells devices, tests, nutrition, and medicines and has a mix that helps it hold up in downturns. The company recently added an oncology testing platform, which increases where its tests can be used and gives the commercial story new momentum. Right now overall price action is weak, so the main case is that the stock should first stabilize before investors reward it.

Primary drivers

  • Broad product mix (devices, tests, nutrition) helps steady sales
  • New oncology platform increases places where tests can be sold
  • Debt and cash look manageable, supporting defensive positioning
  • Price has been weak, creating room for a rebound if momentum firms

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All ABT signals